Research By Sylvester, Collaborators Leads to New Treatment Options for Advanced Myelofibrosis, Other Blood Malignancies
Sylvester Comprehensive Cancer CenterNew research conducted by investigators at Sylvester Comprehensive Cancer Center and collaborating cancer centers indicates that a new type of targeted therapy may offer new treatment options for patients living with advanced myelofibrosis, a bone marrow disorder. Study results will be shared at ASH 2023 in San Diego, Dec. 9-12.